NEW HAVEN, Connecticut (LifeSiteNews) — Yale Medicine and Yale New Haven Hospital are the latest medical institutions to end “transition” procedures for minors, citing changes in federal rules since January.
NBC Connecticut reports that the Yale medical centers will “eliminate the medication treatment component [i.e., transgender hormones] of the gender-affirming program for patients under age 19,” while continuing “mental health” affirmations (Yale’s program reportedly had no “surgical interventions” to be ended).
“We have been carefully monitoring federal executive orders and administrative actions relating to [so-called] gender-affirming care for patients under age 19,” the statement reads. “After a thorough assessment of the current environment, we have made the very difficult decision” to stop administering puberty blockers and cross-sex hormones.
“This decision was not made lightly,” it continues, adding that Yale remains “committed to offering transitional support” while it ceases chemical “transitions.”
“Federal funding should not support interventions that are better delayed until children reach adulthood and can make decisions with full comprehension of the profound consequences for their bodies and futures,” Connecticut Republican state House Minority Leader Vincent Candelora responded.
The news follows similar announcements by Kaiser Permanente, Children’s Hospital Los Angeles, and UChicago Medicine. All were spurred by one of President Donald Trump’s earliest executive actions upon returning to office: an order that ends all federal financial support for “transition” procedures on minors, rescinds or amends all of the Biden health bureaucracy’s past endorsements of underage “transitioning,” and calls for a review of the medical literature on the subject, enforcing all existing restrictions on underage “transitioning,” and taking regulatory action to “end” the practice to the greatest extent possible under current law.
Direct legality of youth “transitions” is currently a matter for individual states to regulate, but the Trump administration has also announced it is investigating institutions that perpetuate it for related crimes that fall under federal jurisdiction, such as misrepresentation and Medicaid fraud.
A large body of evidence shows that “affirming” gender confusion carries serious harms, especially when done with impressionable children who lack the mental development, emotional maturity, and life experience to consider the long-term ramifications of the decisions being pushed on them, or full knowledge about the long-term effects of life-altering, physically transformative, and often irreversible surgical and chemical procedures.
Studies find that more than 80 percent of children suffering gender dysphoria outgrow it on their own by late adolescence and that “reassignment” procedures fail to resolve gender-confused individuals’ heightened tendency to engage in self-harm and suicide – and even exacerbate it, including by reinforcing their confusion and neglecting the actual root causes of their mental strife.
Many oft-ignored detransitioners attest to the physical and mental harm of reinforcing gender confusion as well as to the bias and negligence of the medical establishment on the subject, many of whom take an activist approach to their profession and begin cases with a predetermined conclusion in favor of “transitioning.”
“Gender-affirming” physicians have also been caught on video admitting to more old-fashioned motives for such procedures, as with an 2022 exposé about Vanderbilt University Medical Center’s Clinic for Transgender Health, where Dr. Shayne Sebold Taylor said outright that “these surgeries make a lot of money.”
